Optimi Health Enters Into Psilocybin Supply Agreement With Filament Health

Optimi Health has been engaged by Filament Health to supply psilocybin mushrooms cultivated in Optimi’s recently inaugurated 20,000 square foot EU-GMP Princeton, British Columbia facility in the form of whole, dried mushroom fruiting bodies for potential drug development, testing, and analysis by Filament’s research team.

Become a psychedelic insider!

With a free Blossom membership you will always be in the know.

📰 Weekly newsletter about the psychedelic research

✔️ Unlimited access to our database and original articles

🖊️ Add (private) notes and comments to each page

Make an account
Category Press Release
Published in GlobeNewswire
Country Canada

Companies Featured

Filament Health
Filament Health is a global extraction and drug discovery company. The company have a deep natural psychedelics IP portfolio and are led by an accomplished botanical extraction management team.

Optimi Health
Optimi Health's goal is to bring an evolving product family of functional and psychoactive mushroom-based formulations to the market.

Inline Feedbacks
View all comments